News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PHT Corporation LogPad Chosen By Rinat Neuroscience For First In-Human Trial; Reaching Over 100 Trial Implementations For PHT



10/19/2005 5:08:59 PM

PHT Corporation, maker of LogPad(R), the market-leading electronic patient diary (eDiary) solution for clinical trials, announced today that Rinat Neuroscience Corporation has selected the LogPad for their Phase I Osteoarthritis trial. This 50-subject trial at two US sites incorporates both English and Spanish speaking patients, and contributes to PHT's recent achievement in reaching over 100 sponsor-supported trial implementations worldwide.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES